Cargando…
The contact activation system as a potential therapeutic target in patients with COVID‐19
Coronavirus disease 2019 (COVID‐19) is predicted to overwhelm health care capacity in the United States and worldwide, and, as such, interventions that could prevent clinical decompensation and respiratory compromise in infected patients are desperately needed. Excessive cytokine release and activat...
Autores principales: | Shatzel, Joseph J., DeLoughery, Emma P., Lorentz, Christina U., Tucker, Erik I., Aslan, Joseph E., Hinds, Monica T., Gailani, David, Weitz, Jeffrey I., McCarty, Owen J. T., Gruber, Andras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264624/ https://www.ncbi.nlm.nih.gov/pubmed/32542210 http://dx.doi.org/10.1002/rth2.12349 |
Ejemplares similares
-
Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates
por: Wallisch, Michael, et al.
Publicado: (2020) -
Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
por: Olson, Sven R., et al.
Publicado: (2019) -
Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus
por: Silasi, Robert, et al.
Publicado: (2021) -
The contact pathway and sepsis
por: Raghunathan, Vikram, et al.
Publicado: (2019) -
Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in Mice
por: Bane, Charles E., et al.
Publicado: (2016)